Promoter holding
64.27%
AP
Arcorp Pharmaceuticals Private Limited - Due diligence report
A 360° intelligence report on Arcorp Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gro…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Arcorp Pharmaceuticals Private Limited — 360° Intelligence Report
Generated from MCA filings & public records88/100
Trust Score
Low Risk
Arcorp Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 88/100. Arcorp Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2019, operating in the Healthcare sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 28 Jun 2026 from the latest processed filings. Arcorp Pharmaceuticals Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 1 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 100/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANJNA SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Shiksha Singh | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
06
Ownership & Group Intelligence
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 6 years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence93/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view50/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 8 events30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
Shiksha Singh
26 Feb 2024
Director appointed
Shiksha Singh (Director)
Director ceased
SANTOSH KUMAR JAISWAL
26 Jun 2020
Director ceased
RISHIKESH SINGH
05 Dec 2019
Incorporated
Registered with Roc Gwalior
Director appointed
ANJNA SINGH (Director)
10
Key Observations
Auto-generated from the data aboveCompliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
| Company | CIN | Location |
|---|---|---|
| Tps Enterprises Private Limited | U51397DL2018PTC338464 | Delhi, Delhi, India |
| Chakratech Services Private Limited | U74999RJ2019PTC065653 | Jaipur, Rajasthan, India |
| Rohit Medical Private Limited | U51507WB2004PTC100019 | Kolkata, West Bengal, India |
| Ems Medical Products Private Limited | U24232DL2009PTC188620 | Delhi, Delhi, India |
| Novacure Research Labs Private Limited | U73100TN2019PTC131274 | Perambur Purasawalkam, Tamil Nadu, India |
| Alerthands Healthcare Services Private Limited | U85300KA2019PTC124320 | Bengaluru, Karnataka, India |
| Radik Pharma Private Limited | U24303DL2018PTC334957 | New Delhi, Delhi, India |
| Promissum Healthcare Private Limited | U24290GJ2019PTC108410 | Vadodara, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Arcorp Pharmaceuticals Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Arcorp Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Arcorp Pharmaceuticals Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Arcorp Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Arcorp Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Arcorp Pharmaceuticals Private Limited an active company?
Arcorp Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Arcorp Pharmaceuticals Private Limited financially healthy?
Arcorp Pharmaceuticals Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Arcorp Pharmaceuticals Private Limited?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Arcorp Pharmaceuticals Private Limited?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Arcorp Pharmaceuticals Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Arcorp Pharmaceuticals Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Arcorp Pharmaceuticals Private Limited?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
